Skip to main content
Clinical Trials/NCT04667884
NCT04667884
Completed
Not Applicable

Effects of Prebiotic or Probiotic Supplements on Symptoms of Functional Constipation Among Adults

Health Science Center of Xi'an Jiaotong University1 site in 1 country250 target enrollmentAugust 15, 2020
ConditionsConstipation

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Constipation
Sponsor
Health Science Center of Xi'an Jiaotong University
Enrollment
250
Locations
1
Primary Endpoint
Number of bowel movements per week
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

This study intends to evaluate the effects of three prebiotic solid beverages (mainly dietary fiber and prebiotics) and one probiotic solid beverage on the laxative effect of patients with functional constipation through randomized controlled trials. The influence of tract flora is expected to provide a basis for related therapies for patients with functional constipation.

Registry
clinicaltrials.gov
Start Date
August 15, 2020
End Date
September 30, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Health Science Center of Xi'an Jiaotong University
Responsible Party
Principal Investigator
Principal Investigator

Jiaomei Yang

Assistant Professor

Health Science Center of Xi'an Jiaotong University

Eligibility Criteria

Inclusion Criteria

  • Adults: 18 to 70 years old (not less than 50% of the final population over 45 years old, and not less than 30% of men);
  • Patients with functional constipation (refer to Rome IV diagnostic criteria for functional constipation); \* Symptoms appeared for at least 6 months before diagnosis, and met the above diagnostic criteria in the past 3 months

Exclusion Criteria

  • Pregnant and lactating women;
  • Unable to take the test sample and complete the inspection items as required due to inability to take food by mouth, weakness, allergies or other reasons (including the inability to complete all items due to recent travel plans);
  • Unclear main complaint and obvious abnormal mental state;
  • The liver and kidney function indexes are obviously abnormal (combined with the results of physical examination within the past 1 year);
  • Acute gastrointestinal diseases occurred in the past month, and constipation caused by surgical operations in the past month;
  • Take antibiotics, laxatives or topical agents, anticholinergics, antidiarrheals frequently in the past 1 month, and the frequency is more than 1 time/week
  • Have been diagnosed with the following diseases: cancer (especially cancer of the digestive tract), severe enteritis, intestinal obstruction, inflammatory bowel disease, hypothyroidism, mental illness;
  • Have been diagnosed with the following diseases: severe systemic diseases such as stroke, heart disease, liver cirrhosis, renal failure, hematopoietic system, or qualitative intestinal diseases caused by colonoscopy or imaging display;
  • In the past 3 months, there are often abdominal pain, abdominal pain accompanied by changes in bowel characteristics or frequency, blood in the stool, diarrhea or involuntary weight loss;
  • Clinical manifestations or diseases that other researchers believe are not suitable for participating in the project.

Outcomes

Primary Outcomes

Number of bowel movements per week

Time Frame: week 0 to 4

bowel movements will be recorded per week

Secondary Outcomes

  • glucose(day 0, 14, 28)
  • diversity and abundance of intestinal flora(day 0, 14, 28)
  • HDL-C(day 0, 14, 28)
  • LDL-C(day 0, 14, 28)
  • Classification of bowel status(day 0, 14, 28)
  • Tch(day 0, 14, 28)
  • Bristol classification of stool characteristics(day 0, 14, 28)
  • TG(day 0, 14, 28)

Study Sites (1)

Loading locations...

Similar Trials